商品名：Cefaseptin, Cephacare, Ceporex, Rilexine, Therios
Binds to proteins involved in bacterial cell wall synthesis, thereby decreasing cell wall strength and rigidity, and affecting cell division. Resistant to some bacterial beta-lactamases, particularly those produced by Staphylococcus spp. As for other beta-lactam antibacterials, works in a time-dependent fashion.
Active against several Gram-positive and Gram-negative organisms (e.g. Staphylococcus, Pasteurella and Escherichia coli). Pseudomonas and Proteus are often resistant. Maintaining levels above the MIC is critical for efficacy and prolonged dosage intervals or missed doses can compromise therapeutic response. Dose and Z Y X W V U T S R Q P O N M L K J I H G F E D C B A BSAVA Small Animal Formulary 8th edition 62 dosing interval is determined by infection site, severity and organism. In severe or a
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
D0128 Cefalexin 與 D0141 Cephalexin 是同成分拼法重複；現有劑量又混合美國犬口服、GB 犬貓口服與 GB 犬貓牛注射產品。完成 canonical 去重並強制產品、法域、物種、route、感染、療程、腎功能、年齡／體重、過敏及培養藥敏前，封鎖計算、處方與飼主劑量。
DRUGAPI 劑量審查引用的獸醫官方標示（各標示只適用於其產品、物種與法域，不可互換）
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。